PESCI ALBERTO

Role
Adjunct Lecturer  

Publications

  • Faverio, P., Paciocco, G., Tassistro, E., Rebora, P., Rossi, E., Monzani, A., et al. (2024). Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study. INTERNAL AND EMERGENCY MEDICINE, 19(1 (January 2024)), 183-190 [10.1007/s11739-023-03400-x]. Detail

  • Marchal, A., Cirulli, E., Neveux, I., Bellos, E., Thwaites, R., Schiabor Barrett, K., et al. (2024). Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection. HGG ADVANCES, 5(3) [10.1016/j.xhgg.2024.100300]. Detail

  • Faverio, P., Maloberti, A., Rebora, P., Intravaia, R., Tognola, C., Toscani, G., et al. (2024). Cardiovascular Structural and Functional Parameters in Idiopathic Pulmonary Fibrosis at Disease Diagnosis. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 31(3), 289-297 [10.1007/s40292-024-00638-0]. Detail

  • Faverio, P., Fumagalli, A., Conti, S., Madotto, F., Bini, F., Harari, S., et al. (2023). Short-term Evolution of Nutritional Status in Patients with Idiopathic Pulmonary Fibrosis. ANNALS OF THE AMERICAN THORACIC SOCIETY, 20(7), 1066-1070 [10.1513/AnnalsATS.202211-935RL]. Detail

  • Faverio, P., Ronco, R., Monzio Compagnoni, M., Franchi, M., Franco, G., Bonaiti, G., et al. (2023). Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study. RESPIRATORY RESEARCH, 24(1) [10.1186/s12931-023-02372-y]. Detail

Research projects

Impatto delle terapie biologiche nell'asma severo
Year: 2018
Call: GSK CALL: INNOVATION IN SEVERE REFRACTORY ASTHMA
Grantors: GLAXOSMITHKLINE PLC